The first nomination deadline for MM+M’s 2024 Women of Distinction and Women to Watch programs is quickly approaching. The standard deadline has been set for Wednesday, January 10, and the extended deadline for Wednesday, January 17.
Entering their ninth year, the MM+M Women of Distinction and Women to Watch programs celebrate healthcare marketing executives who have significantly impacted their organizations — and the industry writ large — during the past year. Eligible organizations include biopharma companies, medical device and diagnostics firms, healthcare marketing and communications agencies and health media entities.
In the past, Women of Distinction honorees have typically served in one of several top leadership roles, including CEO, president, chair, EVP, SVP and managing director. Woman to Watch honorees have most often served in mid- to top-level roles, including VP, senior account director, account executive and account director.
“Year in and year out, we’re blown away by the caliber of Women of Distinction and Women to Watch nominees,” said MM+M editor-in-chief Larry Dobrow. “It’s a privilege to shine a spotlight on their achievements. We’ve said it before and we’ll say it again: They represent the best of what the medical marketing business has to offer.”
MM+M will reveal the 2024 honorees in March and they will be celebrated at an event scheduled for June 13 in New York City. Nominations can be submitted here.
For questions about nomination eligibility as well as the Women of Distinction/Women to Watch event, please reach out to MM+M’s Anna Naumoski.
